insights_auto
Why is ALCOX up 4,75%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
0,31 €
arrow_upward
+4,75%(+0,014) 1D
9 ოქტ, 17:35:31 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
0,31 €
High
0,31 €
Low
0,30 €
Mkt. cap
30,14 მლნ.
Avg. vol.
164,58 ათ.
Volume
0,00
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 მლნ.
No. of employees
10
Open
0,31 €
High
0,31 €
Low
0,30 €
Mkt. cap
30,14 მლნ.
Avg. vol.
164,58 ათ.
Volume
0,00
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 მლნ.
No. of employees
10
News stories
From web sources and news partners
Simply Wall Street
·
4 წუთის წინ
Is AI Networking Launch Altering The Investment Case For Broadcom (AVGO)?
Yahoo Finance
·
1 საათის წინ
Dow, S&P 500, Nasdaq Futures Climb After Oil In Focus As Trump Declares ‘Energy Ceasefire’ Between Russia And Ukraine: IREN, WFF, VSTM, CIFR Stocks In Focus
CryptoRank
·
52 წუთის წინ
XRP Faces a Major October 12 Catalyst as Evernorth Debuts on Nasdaq
Barchart.com
·
7 საათის წინ
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, პროვანსი-ალპები-ლაჟვარდოვანი ნაპირი, საფრანგეთი
Sector-
Websitenicox.com